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ABSTRACT 
 
Increasing awareness that the human intestinal flora is a major factor in 
health and disease has led to different strategies to manipulate the flora to 
promote health. These approaches include changes to the diet by inclusion of 
prebiotics and probiotics. Prebiotics are non-digestible polysaccharide food 
ingredients that beneficially affect the host by selectively stimulating the growth 
and/or activity of one or a limited number of bacteria in the gastrointestinal tract 
(GIT). Probiotics on the other hand are viable culture of bacteria, which applied 
to animals or humans, beneficially affect the host by improving the properties of 
the indigenous microflora. One mechanism of action of probiotics is the 
production of antimicrobial substances called bacteriocins, such as colicins, that 
inhibit the growth of their competitors. The experiments described in this thesis 
examined the potential use of prebiotics and probiotics to manipulate GIT 
bacteria. 
A crude polysaccharide extract (HW) from the medicinal mushroom 
Ganoderma lucidium was prepared by extracting the fruiting body with boiling 
water. The extract was then purified by ethanol precipitation resulting in the hot 
water-ethanol (HWE) extract. Groups of mice were fed these extracts over a 
period of three weeks at a concentration of 150 µg/ml in sterile drinking water 
and the mice then euthanised after three weeks. Changes in population 
dynamics of lumen bacteria were determined in the duodenum, ileum, colon 
and faeces by rigorous washing of excised segments while adherent bacteria 
were released with the non-ionic detergent Triton X100, which does not affect 
the viability of the bacteria. The prevalence of haemolytic colonies was 
assessed by plating washouts onto blood agar. Total colony forming units were 
enumerated on bacteriological media selective for Enterobacteriaceae, 
Streptococci, Enterococci and Lactic acid Bacteria (LAB). Results showed that 
there was little change in population dynamics elicited by extract feeding. The 
exception was a significant reduction in haemolytic lumen bacteria and increase 
in LAB lumen bacteria recovered from the colon of HWE treated mice. 
A multiplex PCR was optimized and applied to survey the prevalence of 
eight common colicin genes (Colicins A, D, E1, E2, E6, E7, Ia and V) in 
Escherichia coli (E. coli) isolates. The study focused on 39 clinical isolates from 
 II
humans and 68 isolates from pigs with post-weaning diarrhoea. In addition, 152 
porcine commensal E. coli isolates obtained from different compartments of the 
GIT (duodenum, ileum, colon and faeces) were included in the PCR analysis. 
Six individual colicins (E1, E2, E6, E7, Ia and V) and four dual colicin 
combinations (E1/E2, E1/E7, E2/E7, & E2/Ia) were detected. Approximately 
28.2 % of the human pathogenic isolates had at least one colicin gene with 
colicins D, E1, E7 and V occurring at frequencies of 5.1 % each. Colicins E6, Ia 
and the dual colicin, E2/Ia, were less frequent and were found in about 2.6 % of 
clones. Only 4 % of the porcine pathogenic isolates possessed a colicin gene 
and these were exclusively E1 and V. In contrast, there was a significantly 
higher carriage (36.2%) of colicin genes in commensal porcine E. coli. Of these, 
E1, E7 and Ia accounted for 87 % of all colicin genes detected. Six of the 
commensal strains possessed multiple types of colicins with the most common 
being the E2/E7 combination. Furthermore, there appeared to be differences in 
the type of colicins found in commensal E. coli isolates recovered from different 
intestinal compartments.  
Seven porcine commensal E. coli strains producing standard colicins 
were evaluated for inhibitory activity against five pathogenic E. coli of human 
and porcine origin. The experiment utilized a kinetic inhibitory microtitre assay 
(KIMA) to assess inhibition using non-induced supernatants and supernatants 
induced with 0.2 µg/ml of mitomycin C to stimulate colicin production. The level 
of inhibition was found to be variable with most of the commensal porcine E. coli 
strains showing little or no inhibitory action against the five pathogenic strains. 
However, two commensal strains, ILC33 and CC89 were found to highly 
inhibitory to three porcine pathogenic E. coli  strains of serotypes O141:K85, 
0141:K88 and 0149:K88.  
The findings of this thesis suggest that purified polysaccharide extracts 
(HWE) from Ganoderma lucidium have the potential to be used in further 
studies as prebiotics in view of their positive effects on beneficial LAB. In 
addition, the use of colicin-bearing strains as probiotic bacteria is justifiable 
because of the low incidence of colicin genes in pathogenic E. coli compared to 
commensals. Finally, these findings indicate that potential probiotic bacterial 
strains have to be scrutinised for their inhibitory activity against individual 
pathogenic strains prior to being subjected to further assessments. 
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